Clinical Trial Update: Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports efficacy and safety data for SHR-1314 in patients with active ankylosing spondylitis across Phase 2 and Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• SHR-1314 (SHR-1314)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Ankylosing Spondylitis | Phase 2, Phase 3 | Status: COMPLETED